These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3591681)

  • 1. Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris.
    Magder S; Sami M; Ripley R; Lisbona R
    Am J Cardiol; 1987 Jun; 59(15):1289-94. PubMed ID: 3591681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; Frishman W; Hosler MH; Thorsen NL; Gonasun L; Weinstein J
    Am Heart J; 1982 Aug; 104(2 Pt 2):496-504. PubMed ID: 7102536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
    Choong CY; Roubin GS; Harris PJ; Tokuyasu Y; Shen WF; Bautovich GJ; Kelly DT
    J Cardiovasc Pharmacol; 1986; 8(3):441-8. PubMed ID: 2425156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of pindolol and propranolol on exercise performance in young men with systemic hypertension.
    Martin NB; Broeder CE; Thomas EL; Wambsgans KC; Scruggs KD; Jesek JK; Hofman Z; Wilmore JH
    Am J Cardiol; 1989 Aug; 64(5):343-7. PubMed ID: 2756879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of intrinsic sympathomimetic activity on regional left ventricular function; use of regional ejection fraction to demonstrate a beneficial action by pindolol over propranolol on hypokinetic segments.
    Johnston DL; Manyari DE; Kostuk WJ
    Can J Cardiol; 1985; 1(3):174-9. PubMed ID: 2996726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
    Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
    Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging.
    Dehmer GJ; Falkoff M; Lewis SE; Hillis LD; Parkey RW; Willerson JT
    Br Heart J; 1981 Jun; 45(6):656-66. PubMed ID: 7259915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blind study of pindolol in patients with stable angina pectoris.
    Harston WE; Friesinger GC
    Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
    Ades PA; Brammell HL; Greenberg JH; Horwitz LD
    Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study.
    Winniford MD; Fulton KL; Corbett JR; Croft CH; Hillis LD
    Am J Cardiol; 1985 Feb; 55(4):281-5. PubMed ID: 3969862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma free fatty acids and glycerols during prolonged exercise in trained and hypertensive persons taking propranolol and pindolol.
    Jesek JK; Martin NB; Broeder CE; Thomas EL; Wambsgans KC; Hofman Z; Ivy JL; Wilmore JH
    Am J Cardiol; 1990 Dec; 66(19):1336-41. PubMed ID: 2244564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.
    Frishman W; Kostis J; Strom J; Hossler M; Elkayam U; Goldner S; Silverman R; Davis R; Weinstein J; Sonnenblick E
    Am Heart J; 1979 Oct; 98(4):526-35. PubMed ID: 39447
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Okoli RC; Taylor SH
    Eur J Clin Pharmacol; 1983; 25(2):157-65. PubMed ID: 6628498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; DeFelice EA; Frishman W; Hosler M; Krieger SK; Aglitz N; Kuo PT
    Angiology; 1981 Nov; 32(11):780-7. PubMed ID: 6119937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.